MARKET

COLL

COLL

Collegium Pharm
NASDAQ

Real-time Quotes | Nasdaq Last Sale

18.85
-0.07
-0.37%
Opening 11:26 08/12 EDT
OPEN
19.08
PREV CLOSE
18.92
HIGH
19.56
LOW
18.57
VOLUME
127.12K
TURNOVER
--
52 WEEK HIGH
25.59
52 WEEK LOW
10.41
MARKET CAP
650.81M
P/E (TTM)
-3625.0000
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average COLL stock price target is 28.00 with a high estimate of 35.00 and a low estimate of 8.00.

EPS

COLL News

More
Collegium Pharmaceutical (COLL) Q2 Earnings Miss Estimates
Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of -4.17% and 4.26%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 6d ago
Collegium Reports Net Income of $8.1 Million in the Second Quarter of 2020
– Non-GAAP Net Income of $33.2 Million in the Second Quarter of 2020 – – Generated $43.9 Million in Cash from Operating Activities in the Second Quarter of 2020 –– Xtampza ® ER Net Revenue Increased 29% over the Prior Year Period –– Conference Call Scheduled
GlobeNewswire · 6d ago
Collegium Pharmaceutical Q2 2020 Earnings Preview
Collegium Pharmaceutical (NASDAQ:COLL) is scheduled to announce Q2 earnings results on Tuesday, August 4th, after market close. The consensus EPS Estimate
seekingalpha · 08/05 02:35
Collegium Pharmaceutical's Earnings: A Preview
On Wednesday, August 05, Collegium Pharmaceutical (NASDAQ: COLL) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.Earnings and Revenue Sell-side analysts expect Collegium Pharmaceutical
Benzinga · 08/04 16:04
Did Hedge Funds Make The Right Call On Collegium Pharmaceutical Inc (COLL) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which
Insider Monkey · 08/03 16:59
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy?
Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/29 16:33
Collegium to Host Conference Call to Discuss Second Quarter 2020 Financial Results and Provide Corporate Update
STOUGHTON, Mass., July 21, 2020 -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on.
GlobeNewswire · 07/21 21:00
AMRX vs. COLL: Which Stock Should Value Investors Buy Now?
Zacks · 07/07 16:40

Industry

Pharmaceuticals
+1.97%
Pharmaceuticals & Medical Research
+1.60%

Hot Stocks

Symbol
Price
%Change

About COLL

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company. The Company is engaged in developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its products include Xtampza ER and ONSOLIS. Its DETERx platform provides extended-release drug delivery, while safeguarding against common methods of abuse and tampering, including crushing, chewing, and heating and injecting. Xtampza ER is designed to provide adequate pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. ONSOLIS is a Transmucosal Immediate-Release Fentanyl (TIRF) film indicated for the management of breakthrough pain in cancer patients (BTPc), 18 years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.
More

Webull offers kinds of Collegium Pharmaceutical Inc stock information, including NASDAQ:COLL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COLL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading COLL stock methods without spending real money on the virtual paper trading platform.